AMRX
Price
$8.06
Change
+$0.06 (+0.75%)
Updated
Jul 25 closing price
Capitalization
1.87B
9 days until earnings call
SIGA
Price
$7.14
Change
+$0.08 (+1.13%)
Updated
Jul 25 closing price
Capitalization
608.54M
4 days until earnings call
Interact to see
Advertisement

AMRX vs SIGA

Header iconAMRX vs SIGA Comparison
Open Charts AMRX vs SIGABanner chart's image
Amneal Pharmaceuticals
Price$8.06
Change+$0.06 (+0.75%)
Volume$1.12M
Capitalization1.87B
SIGA Technologies
Price$7.14
Change+$0.08 (+1.13%)
Volume$286.9K
Capitalization608.54M
AMRX vs SIGA Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. SIGA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and SIGA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AMRX: $8.06 vs. SIGA: $7.14)
Brand notoriety: AMRX and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 71% vs. SIGA: 79%
Market capitalization -- AMRX: $1.87B vs. SIGA: $608.54M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileSIGA’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • SIGA’s FA Score: 1 green, 4 red.
According to our system of comparison, SIGA is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • SIGA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRX and SIGA are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.13% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +8.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 05, 2025.

SIGA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than SIGA($609M). AMRX has higher P/E ratio than SIGA: AMRX (90.00) vs SIGA (9.24). SIGA YTD gains are higher at: 31.199 vs. AMRX (1.768). AMRX has higher annual earnings (EBITDA): 400M vs. SIGA (84.2M). SIGA has more cash in the bank: 150M vs. AMRX (91.5M). SIGA has less debt than AMRX: SIGA (564K) vs AMRX (2.75B). AMRX has higher revenues than SIGA: AMRX (2.39B) vs SIGA (140M).
AMRXSIGAAMRX / SIGA
Capitalization1.87B609M307%
EBITDA400M84.2M475%
Gain YTD1.76831.1996%
P/E Ratio90.009.24974%
Revenue2.39B140M1,710%
Total Cash91.5M150M61%
Total Debt2.75B564K487,766%
FUNDAMENTALS RATINGS
AMRX vs SIGA: Fundamental Ratings
AMRX
SIGA
OUTLOOK RATING
1..100
6578
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
5983
SMR RATING
1..100
9938
PRICE GROWTH RATING
1..100
5847
P/E GROWTH RATING
1..100
2734
SEASONALITY SCORE
1..100
5028

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for AMRX (92) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (59) in the Pharmaceuticals Major industry is in the same range as SIGA (83) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew somewhat faster than AMRX’s over the last 12 months.

SIGA's Price Growth Rating (47) in the Pharmaceuticals Other industry is in the same range as AMRX (58) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (27) in the Pharmaceuticals Major industry is in the same range as SIGA (34) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to SIGA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXSIGA
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSPKX23.390.17
+0.73%
Victory RS Partners R
CPTUX92.300.56
+0.61%
Invesco Discovery Large Cap R5
DHIYX20.340.02
+0.10%
Diamond Hill International Y
FIIAX22.85N/A
N/A
Fidelity Advisor Mid Cap II A
NSFMX7.31N/A
N/A
Natixis Target Retirement 2060 N

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.75%
PAHC - AMRX
47%
Loosely correlated
-0.88%
VTRS - AMRX
45%
Loosely correlated
+0.64%
AMPH - AMRX
40%
Loosely correlated
-1.15%
EBS - AMRX
39%
Loosely correlated
-4.02%
ZTS - AMRX
39%
Loosely correlated
-0.46%
More

SIGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIGA has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SIGA jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+1.13%
EBS - SIGA
34%
Loosely correlated
-4.02%
OGI - SIGA
28%
Poorly correlated
+1.32%
CURR - SIGA
26%
Poorly correlated
+3.15%
AMRX - SIGA
25%
Poorly correlated
+0.75%
KMDA - SIGA
24%
Poorly correlated
-0.77%
More